Amenorrhea

CHAPTER 4 Amenorrhea


Amenorrhea is a lack of menstruation that can be the result of primary or secondary causes. Primary amenorrhea is defined as the absence of menarche by 16 years of age with normal pubertal growth and development, the absence of menarche by 14 years of age with lack of normal pubertal growth and development, or the absence of menarche 2 years after sexual maturation is complete. Primary amenorrhea is a rare condition, with constitutional puberty delay the most common cause. One third of primary amenorrhea cases are genetic in nature, such as Turner syndrome or abnormality of the X chromosome.


Secondary amenorrhea is defined as the absence of menstruation for at least three cycles in women with established normal menstruation or 9 months in females with previous oligomenorrhea (menstrual periods occurring at intervals of greater than 35 days, with only four to nine periods in a year). The most common causes of secondary amenorrhea are the physiological events of pregnancy, lactation, and menopause.


The production of menstrual flow requires an intact outflow tract, a hormonally responsive uterus, and an integrated hypothalamic-pituitary-ovarian (HPO) axis. An important task in the diagnostic evaluation of amenorrhea is to identify the malfunctioning element. The primary care provider begins investigation of etiological reasons for amenorrhea and uses that knowledge to determine the type of amenorrhea. In turn, the suspected cause guides diagnostic tests, treatment, and referrals. This method of classification directs the clinician to evaluate constitutional causes, congenital or chronic disorders, the lower genital tract, and then dysfunction of any component of the HPO axis.


The normal menstrual cycle begins with the pulsatile delivery of gonadotropin-releasing hormone (GnRH) by the medial-basal hypothalamus. In response, the posterior pituitary releases luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These influence the growth and development of a follicle and its release of estradiol, which causes the uterine endometrium to proliferate and initiates the LH surge, which is followed by ovulation and menstruation (Figure 4-1 and Table 4-1).




The hypothalamus is also affected by the central nervous system (CNS) and the thyroid gland, which can determine the amount of GnRH received by the pituitary. Alterations in the pattern of GnRH pulsatile release decreases circulating LH and FSH levels; the consequence is an anovulatory menstrual cycle and amenorrhea.


About 66% of all amenorrheic women are hypoestrogenic because of either hypothalamic-pituitary hypofunction or end-organ failure. Determining whether the patient is hypoestrogenic can expedite finding the reason for her amenorrhea and setting the sequencing of laboratory tests. The progesterone challenge test (PCT) causes withdrawal bleeding if there is estrogen production and an adequate outflow tract. The functional status of the pituitary-ovarian unit is assessed by measuring the gonadotropins (LH and FSH).



Diagnostic reasoning: focused history








Seeking pregnancy


Knowing that the patient is seeking pregnancy or, if the patient is pregnant, whether it is intended or unintended allows the interview to be structured appropriately. It also aids in proper counseling and referral. Amenorrheic patients seeking pregnancy who do not bleed after androgen challenge tests are most successfully treated by an infertility specialist. Young maternal age and early referral to a specialist increase a woman’s conception rate.












Apr 10, 2017 | Posted by in NURSING | Comments Off on Amenorrhea

Full access? Get Clinical Tree

Get Clinical Tree app for offline access